Finance

Lists
524715:BOM
Sun Pharmaceutical Industries Ltd
1 760,00 INR
-0,03%
(-0,60) 1D
16 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524715...
Open
1 759,60 INR
High
1 764,40 INR
Low
1 744,85 INR
Mkt. cap
4,22 ტრლ.
Avg. vol.
97,37 ათ.
Volume
35,68 ათ.
Dividend
0,91%
Quarterly dividend
4,00 INR
Ex-dividend date
7 ივლ. 2026
P/E ratio
34,89
52-wk high
2 047,55 INR
52-wk low
1 583,60 INR
EPS
50,44 INR
Shares outstanding
0,00
No. of employees
47 ათ.
Open
1 759,60 INR
High
1 764,40 INR
Low
1 744,85 INR
Mkt. cap
4,22 ტრლ.
Avg. vol.
97,37 ათ.
Volume
35,68 ათ.
Dividend
0,91%
Quarterly dividend
4,00 INR
Ex-dividend date
7 ივლ. 2026
P/E ratio
34,89
52-wk high
2 047,55 INR
52-wk low
1 583,60 INR
EPS
50,44 INR
Shares outstanding
0,00
No. of employees
47 ათ.
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
1 დღის წინ
Sun Pharma stock: Results are due October 29 for Sun Pharma stock
ad-hoc-news.de
ad-hoc-news.de
·
2 დღის წინ
Analyst consensus puts Sun Pharma stock at INR 2,180.00
Profile
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
About Sun Pharmaceutical Industries Ltd
CEO-
Employees47 ათ.
Founded1983
HeadquartersGoregaon East, მუმბაი, ინდოეთი
SectorPharmaceutical industry
Websitesunpharma.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
144,78 მლრ.
155,21 მლრ.
146,12 მლრ.
153,00 მლრ.
Cost of goods sold
29,83 მლრდ.
29,45 მლრდ.
37,36 მლრდ.
29,63 მლრდ.
Cost of revenue
29,83 მლრდ.
29,45 მლრდ.
37,36 მლრდ.
29,63 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27,65 მლრდ.
28,92 მლრდ.
30,60 მლრდ.
32,27 მლრდ.
Operating expense
81,28 მლრდ.
85,13 მლრდ.
80,66 მლრდ.
87,80 მლრდ.
Total operating expenses
111,11 მლრ.
114,58 მლრ.
118,02 მლრ.
117,43 მლრ.
Operating income
33,67 მლრდ.
40,62 მლრდ.
28,10 მლრდ.
35,57 მლრდ.
Other non operating income
4,70 მლრდ.
5,79 მლრდ.
-14,29 მლრდ.
7,24 მლრდ.
EBT including unusual items
41,55 მლრდ.
42,07 მლრდ.
35,37 მლრდ.
40,89 მლრდ.
EBT excluding unusual items
41,55 მლრდ.
46,97 მლრდ.
26,83 მლრდ.
42,93 მლრდ.
Income tax expense
10,31 მლრდ.
8,26 მლრდ.
8,28 მლრდ.
11,88 მლრდ.
Effective tax rate
24,80%
19,63%
23,40%
29,05%
Other operating expenses
46,34 მლრდ.
48,89 მლრდ.
42,30 მლრდ.
48,14 მლრდ.
Net income
31,18 მლრდ.
33,69 მლრდ.
27,14 მლრდ.
28,95 მლრდ.
Net profit margin
21,54%
21,71%
18,57%
18,92%
Earnings per share
13,00
15,48
11,30
12,71
Interest and investment income
-
-
9,74 მლრდ.
-
Interest expense
-998,60 მლნ.
-783,60 მლნ.
-858,90 მლნ.
-996,70 მლნ.
Net interest expenses
-998,60 მლნ.
-783,60 მლნ.
8,89 მლრდ.
-996,70 მლნ.
Depreciation and amortization charges
7,30 მლრდ.
7,32 მლრდ.
7,75 მლრდ.
7,39 მლრდ.
EBITDA
40,82 მლრდ.
46,53 მლრდ.
34,86 მლრდ.
42,32 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები